Compare Orchid Chemicals with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs TTK HEALTHCARE - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD TTK HEALTHCARE ORCHID PHARMA LTD/
TTK HEALTHCARE
 
P/E (TTM) x -0.5 18.3 - View Chart
P/BV x 0.1 1.5 8.1% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 ORCHID PHARMA LTD   TTK HEALTHCARE
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
TTK HEALTHCARE
Mar-19
ORCHID PHARMA LTD/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1941,215 16.0%   
Low Rs35610 5.7%   
Sales per share (Unadj.) Rs276.5444.4 62.2%  
Earnings per share (Unadj.) Rs-79.217.2 -459.3%  
Cash flow per share (Unadj.) Rs-43.527.6 -157.3%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs53.9177.9 30.3%  
Shares outstanding (eoy) m70.4514.13 498.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.1 20.2%   
Avg P/E ratio x-1.452.9 -2.7%  
P/CF ratio (eoy) x-2.633.0 -8.0%  
Price / Book Value ratio x2.15.1 41.4%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m8,06712,894 62.6%   
No. of employees `0002.82.3 121.1%   
Total wages/salary Rs m2,5271,307 193.3%   
Avg. sales/employee Rs Th6,956.12,715.7 256.1%   
Avg. wages/employee Rs Th902.5565.3 159.6%   
Avg. net profit/employee Rs Th-1,993.0105.4 -1,890.7%   
INCOME DATA
Net Sales Rs m19,4776,279 310.2%  
Other income Rs m40778 525.4%   
Total revenues Rs m19,8846,356 312.8%   
Gross profit Rs m1,103496 222.5%  
Depreciation Rs m2,519147 1,717.2%   
Interest Rs m5,22734 15,463.9%   
Profit before tax Rs m-6,236393 -1,588.4%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125149 -84.1%   
Profit after tax Rs m-5,580244 -2,289.8%  
Gross profit margin %5.77.9 71.7%  
Effective tax rate %2.037.9 5.3%   
Net profit margin %-28.73.9 -738.2%  
BALANCE SHEET DATA
Current assets Rs m11,0142,717 405.4%   
Current liabilities Rs m32,0601,571 2,041.0%   
Net working cap to sales %-108.118.3 -591.8%  
Current ratio x0.31.7 19.9%  
Inventory Days Days9532 295.1%  
Debtors Days Days3447 71.9%  
Net fixed assets Rs m29,440991 2,970.7%   
Share capital Rs m705141 498.6%   
"Free" reserves Rs m2,0432,373 86.1%   
Net worth Rs m3,8002,514 151.1%   
Long term debt Rs m9,0183 265,232.4%   
Total assets Rs m46,5104,158 1,118.5%  
Interest coverage x-0.212.6 -1.5%   
Debt to equity ratio x2.40 175,497.7%  
Sales to assets ratio x0.41.5 27.7%   
Return on assets %-0.86.7 -11.4%  
Return on equity %-146.99.7 -1,515.1%  
Return on capital %-3.716.9 -22.1%  
Exports to sales %37.93.6 1,056.1%   
Imports to sales %22.60.5 4,589.3%   
Exports (fob) Rs m7,378225 3,276.0%   
Imports (cif) Rs m4,40631 14,236.2%   
Fx inflow Rs m7,513225 3,336.3%   
Fx outflow Rs m5,64971 7,943.7%   
Net fx Rs m1,865154 1,210.0%   
CASH FLOW
From Operations Rs m1,682173 971.5%  
From Investments Rs m-9,86097 -10,218.0%  
From Financial Activity Rs m6,644-307 -2,162.0%  
Net Cashflow Rs m-1,535-38 4,071.6%  

Share Holding

Indian Promoters % 32.3 65.4 49.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 3.7 124.3%  
FIIs % 3.3 5.2 63.5%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 25.8 214.3%  
Shareholders   84,811 12,723 666.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  PLETHICO PHARMA  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS